Maintaining a steady blood glucose level in individuals with diabetes often requires a continuous, low-dose insulin infusion. This foundational insulin requirement, mimicking the pancreas’s natural function between meals and overnight, is determined through a process of evaluating factors like fasting glucose levels, overnight glucose patterns, and individual insulin sensitivity. For instance, a physician might start a patient on 10 units of long-acting insulin and adjust the dosage based on subsequent glucose readings.
Proper management of this fundamental insulin need is essential for overall glycemic control, reducing the risk of both hyperglycemia and hypoglycemia. Historically, achieving stable blood sugar levels relied heavily on intermediate-acting insulin, but advancements in long-acting insulin analogs have significantly improved the ability to mimic natural pancreatic function. This provides more predictable and stable glucose control, minimizing fluctuations and improving quality of life for individuals with diabetes.
